Génomic Vision SAの株式の価格
Génomic Vision SAの株式の価格 は何ですか。
Génomic Vision SAの株式の価格 は0.02です。
株式の価格 の定義は何ですか。
1株当たりキャッシュは、会社の手持ち現金を会社の発行済株式で割ったものです。
Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.
When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.
EURONEXTのセクタHealth Careにおける株式の価格 の企業と比べるGénomic Vision SA
Génomic Vision SAは何をしますか。
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
Génomic Vision SAと類似の株式の価格
- Orgenesis Incの株式の価格 は0.02です。
- Midland Ic&I Ltdの株式の価格 は0.02です。
- Golden Arrow Resourcesの株式の価格 は0.02です。
- Elsightの株式の価格 は0.02です。
- Threat Protect Australiaの株式の価格 は0.02です。
- Golden Faithの株式の価格 は0.02です。
- Génomic Vision SAの株式の価格 は0.02です。
- China Chuanglian Educationの株式の価格 は0.02です。
- ELL Environmentalの株式の価格 は0.02です。
- Jervois Miningの株式の価格 は0.02です。
- Graphite Oneの株式の価格 は0.02です。
- Juniper IIの株式の価格 は0.02です。
- AMCI Acquisitionの株式の価格 は0.02です。